The company launched a Phase 2 Long COVID study to evaluate whether immune activation with Anktiva can improve recovery by restoring NK and CD8 T cells. ・The open-label study plans to enroll about 20 ...

Comparison of Breast Cancer Recurrence and Outcome Patterns Between Patients Treated From 1986 to 1992 and From 2004 to 2008 Flow cytometry of peripheral blood lymphocytes revealed dramatic efflux of ...

Researchers developed MIL33B, a high-affinity antibody that selectively targets the tumor-associated 4Ig-B7-H3 isoform while ...

Study uncovers a pathogenic subset of memory T-cells that promote tissue inflammation and highlights a potential target for treating nasal polyps and other inflammatory airway diseases. Study: ...